المؤلفون: Jeffrey E. Gershenwald, Jennifer A. Wargo, Richard A. Scolyer, Isabella C. Glitza Oliva, Matteo S. Carlino, Hussein Abdul-Hassan Tawbi, Alexander J. Lazar, Anthony Lucci, Michael T. Tetzlaff, Sherise D. Ferguson, Serigne Lo, Rodabe N. Amaria, Lauren E. Haydu, Robyn P. M. Saw, John F. Thompson, Jeffrey E. Lee, Jonathan R. Stretch, Sapna Pradyuman Patel, Adi Diab, Patrick Hwu, Alexander M. Menzies, Michael A. Davies, Kerwin F. Shannon, Merrick I. Ross, Georgina V. Long, Andrew J. Spillane, Michael K.K. Wong, Janice N. Cormier, Jennifer L. McQuade

المصدر: J Clin Oncol

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Multivariate analysis, Adolescent, Risk Assessment, Central Nervous System Neoplasms, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Original Reports, Humans, Medicine, Cumulative incidence, Stage III melanoma, 030212 general & internal medicine, Young adult, Melanoma, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Incidence, Incidence (epidemiology), Australia, Cancer, Middle Aged, Prognosis, medicine.disease, United States, CNS metastasis, 030220 oncology & carcinogenesis, Multivariate Analysis, Female, Neoplasm Recurrence, Local, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904c4fd0c7c8f5a78baaaf34279588a2Test
https://doi.org/10.1200/jco.19.01508Test

المؤلفون: Rodabe N. Amaria, Asim Amin, Hussein Abdul-Hassan Tawbi, Jessica Michaud Davis, Kourtney Holbrook, Isabella C. Glitza, Michael A. Davies, Sapna Pradyuman Patel, Adi Diab, Jose Lutzky

المصدر: Cancer

مصطلحات موضوعية: Oncology, BRAF inhibitor, Adult, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Combination therapy, encorafenib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Encorafenib, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, In patient, 030212 general & internal medicine, Neoplasm Metastasis, Prospective cohort study, Melanoma, Protein Kinase Inhibitors, antitumor, MEK inhibitor, Sulfonamides, business.industry, Brain Neoplasms, Binimetinib, Original Articles, Middle Aged, medicine.disease, MAP Kinase Kinase Kinases, 3. Good health, chemistry, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, binimetinib, Original Article, Benzimidazoles, Female, Carbamates, Disease Site, business, melanoma‐associated brain metastasis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d272b8fe781b617355a302ffec361e5Test
http://europepmc.org/articles/PMC7004095Test

المؤلفون: Edward Chu, Hussein Abdul-Hassan Tawbi, Jan H. Beumer, Leonard Joseph Appleman, John C. Rhee, Jonas Scemama, Ken Czambel, Shaoyu Wu, John C. Schmitz, Etctn Study Team, John Wright, William F. Maguire, Huang Lin, Shannon Puhalla, James J. Lee, Yan Lin, Ronald G. Stoller, Anthony Green

المصدر: Cancer Chemother Pharmacol

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Bevacizumab, medicine.drug_class, Toxicology, Tyrosine-kinase inhibitor, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pharmacokinetics, Tubulin, Internal medicine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Tivantinib, Aged, Pharmacology, Aged, 80 and over, biology, Dose-Response Relationship, Drug, business.industry, Middle Aged, Proto-Oncogene Proteins c-met, Pyrrolidinones, 030104 developmental biology, Treatment Outcome, chemistry, Mechanism of action, 030220 oncology & carcinogenesis, Pharmacodynamics, Toxicity, biology.protein, Quinolines, Female, medicine.symptom, Antibody, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa3d95b1b12f5ec72f723f2552ce797Test
https://europepmc.org/articles/PMC8628145Test/

المؤلفون: Laszlo Radvanyi, Cara Haymaker, Sapna Pradyuman Patel, Adi Diab, Elizabeth J. Shpall, Roland L. Bassett, Rodabe N. Amaria, Chantal Saberian, Patrick Hwu, Hussein Abdul-Hassan Tawbi, Sapna R. Parshottam, Marie Andrée Forget, Amer Najjar, Jennifer L. McQuade, Michael A. Davies, Gregory Lizée, Chantale Bernatchez, Victor G. Prieto, Cassian Yee, Silvana de Castro Faria, Isabella C. Glitza, Michael K. Wong, Enrique Alvarez

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)

مصطلحات موضوعية: Oncology, lymphocytes, Male, Cancer Research, Adoptive cell transfer, Skin Neoplasms, Time Factors, T-Lymphocytes, Immunotherapy, Adoptive, Clinical endpoint, Immunology and Allergy, RC254-282, Clinical/Translational Cancer Immunotherapy, medicine.diagnostic_test, integumentary system, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, hemic and immune systems, adaptive immunity, Middle Aged, Acquired immune system, Combined Modality Therapy, Treatment Outcome, Molecular Medicine, Female, Adult, medicine.medical_specialty, Adolescent, Immunology, chemical and pharmacologic phenomena, Cancer Vaccines, Lymphocyte Depletion, Flow cytometry, Young Adult, Lymphocytes, Tumor-Infiltrating, MART-1 Antigen, Internal medicine, medicine, melanoma, Humans, dendritic cells, neoplasms, Neoplasm Staging, Pharmacology, business.industry, Tumor-infiltrating lymphocytes, Dendritic cell, tumor-infiltrating, medicine.disease, vaccination, business, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f052eba42b567597c919c4ddda389464Test
http://europepmc.org/articles/PMC8144048Test

المؤلفون: Neil D. Gross, Randal S. Weber, Wen-Jen Hwu, Jeffrey E. Lee, Shaojun Zhang, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Padmanee Sharma, Alexander J. Lazar, Rodabe N. Amaria, Merrick I. Ross, Amy C. Hessel, Christine N. Spencer, Lauren Simpson, Richard A. Ehlers, Jeffrey E. Gershenwald, Michael A. Davies, Michael K. Wong, Hussein Abdul-Hassan Tawbi, James P. Allison, Liberty Posada, Daniel K. Wells, Robin Kageyama, Sapna Pradyuman Patel, Isabella C. Glitza, Adi Diab, Denái R. Milton, Michael T. Tetzlaff, Richard E. Royal, Scott E. Woodman, Carol M. Lewis, Miles C. Andrews, Alexandre Reuben, Sangeetha M. Reddy, Lauren E. Haydu, Victor G. Prieto, Ehab Y. Hanna, Patrick Hwu, Elizabeth M. Burton, Janice N. Cormier, Jennifer A. Wargo, Anthony Lucci, Stephen Y. Lai, Jorge Blando, Linghua Wang

المصدر: Nature medicine

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Phases of clinical research, Ipilimumab, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, Article, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Melanoma, Neoadjuvant therapy, Neoplasm Staging, business.industry, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Immune checkpoint, Neoadjuvant Therapy, 3. Good health, 030104 developmental biology, Nivolumab, 030220 oncology & carcinogenesis, Female, business, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a93e1b3edc623951587af2feeb3e914Test
http://europepmc.org/articles/PMC6481682Test

المؤلفون: Lauren E. Haydu, Sapna Pradyuman Patel, Adi Diab, Hussein Abdul-Hassan Tawbi, Michael A. Davies, Suhendan Ekmekcioglu, Jennifer L. McQuade, Isabella C. Glitza, Dai Ogata, Michael K. Wong, Rodabe N. Amaria

المصدر: Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2293-2299 (2021)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Skin Neoplasms, Programmed Cell Death 1 Receptor, Kaplan-Meier Estimate, Gastroenterology, 0302 clinical medicine, mucosal melanoma, Immune Checkpoint Inhibitors, Melanoma, Original Research, Aged, 80 and over, Standard treatment, Hazard ratio, Mucosal melanoma, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, Nivolumab, Oncology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, anti‐PD‐1, malignant melanoma, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, 03 medical and health sciences, Young Adult, Rare Diseases, Internal medicine, medicine, Confidence Intervals, Humans, Radiology, Nuclear Medicine and imaging, Aged, Retrospective Studies, L-Lactate Dehydrogenase, Proportional hazards model, business.industry, Clinical Cancer Research, Retrospective cohort study, medicine.disease, Confidence interval, acral melanoma, 030104 developmental biology, Cutaneous melanoma, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe0fb7a0e7c6fe38c492eb72997b301Test
https://pubmed.ncbi.nlm.nih.gov/33686688Test

المؤلفون: Eduard Gasal, Paul Nathan, Antoni Ribas, Neha Pakhle, Victoria Atkinson, Céleste Lebbé, Dirk Schadendorf, Mario Mandalà, Daniel Gusenleitner, Paolo A. Ascierto, Aisha Masood, Erika Richtig, Catarina D. Campbell, Reinhard Dummer, Ana Arance, Keith T. Flaherty, Hussein Abdul-Hassan Tawbi, Naoya Yamazaki, Georgina V. Long, Caroline Robert, Jan C. Brase

المساهمون: University of Zurich, Dummer, Reinhard

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Skin Neoplasms, Medizin, Cohort Studies, 0302 clinical medicine, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Oximes, Clinical endpoint, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Melanoma, Trametinib, MEK inhibitor, Imidazoles, 10177 Dermatology Clinic, General Medicine, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Biomarker (medicine), Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, Mutation, Missense, 610 Medicine & health, Genetics and Molecular Biology, Pyrimidinones, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Young Adult, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Biomarkers, Tumor, Humans, Protein Kinase Inhibitors, Aged, business.industry, Dabrafenib, medicine.disease, Clinical trial, Regimen, 030104 developmental biology, General Biochemistry, business

وصف الملف: 870_Dummer_R._et_al._Combined_PD-1,_BRAF_and_MEK_inhibition_in_advanced_BRAF-mutant_melanoma_Nature_Medicine_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b17ee96d80a3281cdd7448c58c9110fTest
https://www.ncbi.nlm.nih.gov/pubmed/33020648Test

المؤلفون: Isabella C. Glitza, Joshua Upshaw, Patrick Hwu, Richard E. Royal, Mandar Karhade, Michael A. Davies, Carolyn S. Hall, Merrick I. Ross, Jeffrey E. Lee, Hussein Abdul-Hassan Tawbi, Anthony Lucci, Rodabe N. Amaria, Jennifer A. Wargo, Michael K.K. Wong, Jessica B. Bowman Bauldry, Boomadevi Narendran, Sapna Pradyuman Patel, Adi Diab, Jeffrey E. Gershenwald

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 26(8)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Early Relapse, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Internal medicine, Biomarkers, Tumor, Medicine, Humans, Stage III melanoma, Prospective Studies, Stage (cooking), Melanoma, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Proportional hazards model, Middle Aged, medicine.disease, Neoplastic Cells, Circulating, Primary tumor, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Disease Progression, Female, Lymph Nodes, Stage IIIa, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe1cd705575a98471898584b36d274aTest
https://pubmed.ncbi.nlm.nih.gov/32015020Test

المؤلفون: Isabella C. Glitza, Anthony Lucci, Michael K. Wong, Wen-Jen Hwu, Richard E. Royal, James P. Allison, Alexander J. Lazar, Alexandre Reuben, Scott E. Woodman, P.A. Futreal, Padmanee Sharma, Sapna Pradyuman Patel, Adi Diab, Patrick Hwu, Zachary A. Cooper, Christine N. Spencer, Courtney W. Hudgens, Rodabe N. Amaria, Michael A. Davies, Jeffrey E. Gershenwald, Haifeng Zhu, Michael T. Tetzlaff, Peter A. Prieto, Jeffrey E. Lee, Jennifer A. Wargo, Rosalind Mouton, Vancheswaran Gopalakrishnan, Jennifer L. McQuade, Elizabeth M. Burton, Merrick I. Ross, Lauren Simpson, Miles C. Andrews, Hussein Abdul-Hassan Tawbi, Khalida Wani, Sangeetha M. Reddy, Li Zhao, Roland L. Bassett, Janice N. Cormier

المصدر: The Lancet Oncology. 19:181-193

مصطلحات موضوعية: 0301 basic medicine, Oncology, Skin Neoplasms, medicine.medical_treatment, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Oximes, Clinical endpoint, Melanoma, Neoadjuvant therapy, Trametinib, Academic Medical Centers, education.field_of_study, Imidazoles, Standard of Care, Middle Aged, Prognosis, Texas, Neoadjuvant Therapy, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, medicine.drug, Adult, medicine.medical_specialty, Pyridones, Population, Pyrimidinones, Cancer Care Facilities, Risk Assessment, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Confidence Intervals, medicine, Adjuvant therapy, Humans, Neoplasm Invasiveness, education, Aged, Neoplasm Staging, business.industry, Dabrafenib, Mohs Surgery, Survival Analysis, Clinical trial, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab690f1022d28461b6e4ffd40f8fb279Test
https://doi.org/10.1016/s1470-2045Test(18)30015-9

المؤلفون: Brian A. Van Tine, Jennifer A. Wargo, Richard F. Riedel, Emily Z. Keung, Sujana Movva, Jaime Rodrigues-Canales, Hussein Abdul-Hassan Tawbi, Edwin R. Parra, Christina L. Roland, Alexandre Reuben, Melissa Amber Burgess, Lara E. Davis, Denise K. Reinke, Alexander J. Lazar, James C. Hu, Steven Attia, Scott M. Schuetze, Dennis A. Priebat, Ruth Salazar, Vanessa Bolejack, Damon R. Reed, Wei Lien Wang, Scott H. Okuno

المصدر: Clin Cancer Res

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, Programmed Cell Death 1 Receptor, Soft Tissue Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, Undifferentiated Pleomorphic Sarcoma, B7-H1 Antigen, Article, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Lymphocytes, Tumor-Infiltrating, Internal medicine, medicine, Biomarkers, Tumor, Cytotoxic T cell, Humans, Survival rate, Aged, Aged, 80 and over, business.industry, Sarcoma, Middle Aged, medicine.disease, Survival Rate, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Monoclonal, Female, business, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6d7c8c1604143470cb044f24b36f75Test
https://pubmed.ncbi.nlm.nih.gov/31900276Test